DMCC shifts speciality growth beyond structurally weak Europe
Key highlights
- DMCC management said Europe’s chemical-industry weakness is structural and it does not expect great growth there.
- DMCC said Latin America and Japan have delivered good success, while Korea is under development.
- DMCC reported Q2 FY27 turnover of about Rs 273 crore and EBITDA of Rs 11.6 crore.
- DMCC said it has at least 25% to 30% downstream capacity room for expansion.
powered by IRIS

DMCC Speciality Chemicals Limited is redirecting speciality-chemical growth from Europe to Latin America, Japan, Korea and India after management said on November 18, 2026 that it did not expect great European growth, while retaining 25% to 30% capacity room for downstream expansion. Management said the newer overseas markets can maintain margins.
Know DMCC Speciality Chemicals inside out
Results, valuation, peers and who's buying, in one view.
Why is DMCC shifting speciality growth beyond Europe?
DMCC is shifting its growth focus because management considers Europe’s chemical-industry problem structural rather than cyclical. Managing Director and Chief Executive Officer Bimal Goculdas said Europe faces high energy costs and problems with its integration, and that a recovery would require fundamental policy changes to protect the region’s chemical industry.
Management’s position is that DMCC will retain its existing European business but should not plan for significant incremental growth there. Goculdas said the company believes the destruction likely to occur in Europe has already happened. He said coordinated action was more difficult in Europe because multiple countries would need to agree despite not all having a chemical industry.
The strategy matters because speciality chemicals are intended to become a larger part of DMCC’s operating mix, while reported revenue has been distorted by the commodity sulphur cycle. In Q2 FY27, DMCC reported turnover of about Rs 273 crore and earnings before interest, tax, depreciation and amortisation, or EBITDA, of Rs 11.6 crore. Management said elevated sulphur prices made the commodity business appear larger in revenue terms than its normal operating level.
Which markets is DMCC using to replace European growth?
DMCC is pursuing Latin America, Japan, Korea and India as markets for speciality-chemical growth outside Europe. Management said it had achieved good success in Latin America and Japan, was exploring Korea and hoped to see developments there soon. It also said the Indian speciality-chemicals business offered good growth.
The company described this as a market-development effort rather than a capacity constraint. During the Q2 FY27 call, management said the speciality business had gained traction in new overseas countries, although the result was overshadowed by sulphur-price volatility. Management said absolute exports were higher than both the preceding quarter and the previous year; an analyst on the call said exports were about 12% of Q2 revenue.
DMCC did not disclose country-level revenue, sales volumes, customer additions or a timetable for Korea. That leaves the scale of the replacement opportunity unquantified. The stated plan is to retain the European business that remains, pursue incremental business in Latin America and Japan, develop Korea, and grow the Indian speciality portfolio rather than depend on a European recovery.
Can DMCC maintain margins in Latin America, Japan and Korea?
DMCC said it can maintain margins in the Latin American and Asian opportunities that are replacing Europe-led growth. This was management’s direct response when asked whether the newer markets required a profitability trade-off to protect volumes. The Q2 FY27 call did not provide segment margins, country margins or product-level pricing for those export markets.
That statement sits alongside DMCC’s product-development programme. DMCC has begun commercial supplies of an intermediate used in a polymer for enhanced oil recovery, with customer approvals completed. Management expects this single product, sold to multiple customers, to generate annualised revenue of Rs 25 crore to Rs 50 crore, although it did not specify when that annualised range would be reached.
DMCC is also developing two boron-based fine-chemical products, one for catalytic use and another as an agrochemical intermediate. Management said their margin profile should be substantially better than the existing profile, but did not disclose revenue targets, launch dates or capital requirements. These products could change the speciality mix independently of the geographic shift away from Europe.
Got a follow-up? Ask IRIS
How much room does DMCC have for speciality expansion?
DMCC said it has at least 25% to 30% room to expand across its downstream product operations before requiring a major new plant. Management added that some expansion could be completed with very low capital expenditure, or CAPEX, instead of building an entire facility. Utilisation varies by downstream product, so DMCC did not provide a single plant-wide utilisation figure.
Management framed the speciality opportunity as constrained by market development rather than production capacity. It told the Q2 FY27 call that, if sulphur returned to pre-war levels of about $500 a tonne, DMCC would be close to a 50-50 split between speciality and commodity activity. The current revenue mix is skewed because sulphur and sulphuric-acid prices mechanically inflate commodity sales values.
The available headroom gives DMCC scope to support newer overseas markets while developing products for domestic customers. Management said a completely new product could require an entirely new plant. It also said research and development spending would increase in coming quarters and that this plan remained on course, without giving an amount or scheduled start date.
How did sulphur volatility shape DMCC’s market strategy?
Sulphur volatility reduced Q2 FY27 profitability and reinforced DMCC’s focus on downstream speciality chemicals. Sulphur was about $500 a tonne before the Iran crisis, rose to as much as $1,100 to $1,200 a tonne afterwards, and started to taper only after the quarter. Management said it could pass through the price increase in Q1 but could not do so in Q2 because end markets resisted sulphuric-acid prices.
DMCC responded by cutting acid-plant operating rates rather than selling incremental material below cost. Management illustrated that, for a plant with capacity of 100, DMCC ran at about 65 in Q2. It kept the plant running only to the extent needed for speciality products, rather than shutting it down, because shutdowns and restarts are expensive.
This created a contrast between reported revenue and earnings. Q2 turnover of about Rs 273 crore reflected the higher raw-material-linked selling price, but EBITDA was Rs 11.6 crore as the sale-to-raw-material-cost spread narrowed. Management also said lower acid production reduced utility output that would normally support operations, creating both margin pressure and lower absorption of overheads.
Demand destruction extended beyond DMCC’s customer base. Management identified fertilisers as among the first affected sectors and said Gujarat State Fertilizer Corporation shut fertiliser operations and sold sulphuric acid into the market at a low price. Detergents and other downstream chemical producers also reduced output, while management said pricing and availability had begun to ease after October.
Conclusion
DMCC’s stated strategy is to treat Europe as a business to preserve rather than its principal source of new speciality growth. Latin America, Japan, Korea and India are the intended alternatives, and management says those markets can maintain margins. The company’s 25% to 30% downstream capacity room, plus commercial supply of an enhanced-oil-recovery intermediate, provides an operating base for that plan.
The next issue to watch is whether lower sulphur prices restore acid demand and improve the spread that compressed Q2 FY27 EBITDA to Rs 11.6 crore. Management’s planned rise in research and development spending, progress in Korea, and conversion of the Rs 25 crore to Rs 50 crore annualised revenue opportunity for the polymer intermediate into sales are additional milestones to monitor.


